[VYNE] QoQ Quarter Result on 31-Mar-2019 [#Q1]

Stock
[VYNE] VYNE Therapeutics Inc.
Announcement Date
02-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- -7.27%
YoY- -49.11%
Quarter Report
VYNE's Result
VYNE's Financial Summary
View:
Show?
Quarter Result
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Revenue 0 0 0 0 -10,640 0 10,143 -
PBT -21,498 -16,855 -16,477 -18,873 -17,594 -12,847 -8,347 87.56%
Tax -52,379 0 0 0 -11 0 0 -
NP -21,498 -16,855 -16,477 -18,873 -17,594 -12,847 -8,347 87.56%
Tax Rate - - - - - - - -
Total Cost 21,498 16,855 16,477 18,873 6,954 12,847 18,490 10.54%
Ratio Analysis
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 165.36 0.00 -82.29 -
Per Share
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
EPS -64.36 -50.66 -49.65 -58.35 -54.68 -40.26 -26.28 81.39%
EPS Diluted -64.36 -50.66 -49.65 -58.35 -54.68 -40.26 -26.28 81.39%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.